ClinicalTrialsFinder

Colorectal, Cancer Clinical Trials in Beijing, Biotherapeutic Department of Chinsese PLA Gereral Hospital

1 recruitingBeijing, Biotherapeutic Department of Chinsese PLA Gereral Hospital, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

GSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC.

Colorectal, Cancer
Chinese PLA General Hospital120 enrolled1 locationNCT06558773